4
Changes in Ownership
Phreesia, Inc. Filed Acc 0001127602-24-029339
SVP, Life Sciences sold 11,853 shares at $24.85 ($294,559)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Linetsky David · SVP, Life Sciences
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-11 | Sale : show line 1 in the form 10b5-1 | −11,853 | $24.85 | $294,559 | 188,354 | D |
| Open-market sales · 11,853 sh · avg $24.85 · $294,559 | ||||||
Loading xslF345X05/form4.xml…